SYNH Past Earnings image   This SYNH past earnings page last updated 10/6/2023
SYNH Past Earnings
PeriodPast Earnings DateEarnings
Q2 20238/8/20230.010
Q1 20235/10/20230.750
Q4 20222/16/20231.230
Q3 202211/4/20221.230
Q2 20228/2/20221.250
Q1 20224/29/20221.010
Q4 20212/17/20221.480
Q3 202111/3/20211.220
Q2 20218/9/20210.970
Q1 20214/29/20210.790
Q4 20202/18/20211.110
Q3 202010/29/20201.040
Q2 20208/6/20200.580
Q1 20204/30/20200.680
Q4 20192/20/20201.030
Q3 201910/31/20190.870
Q2 20198/6/20190.740
Q1 20195/9/20190.590
Q4 20183/18/20190.95
Q3 201811/6/20180.75
Q2 20188/2/20180.62
Q1 20185/9/20180.55
Q4 20172/28/20180.7
Q3 201711/9/20170.54
Q2 20177/27/20170.64
Q1 20175/10/20170.6
Q4 20162/28/20170.67
Q3 201610/31/20160.64
Q2 20167/28/20160.61
Q1 20165/2/20160.58
Q4 20152/25/20160.54
Q3 201510/29/20150.58
Q2 20157/30/20150.47
Q1 20154/27/20150.42
Q4 20142/24/20150.26
SYNH Past Revenue
PeriodPast Earnings DateRevenue
Q2 20238/8/20231.37B
Q1 20235/10/20231.36B
Q4 20222/16/20231.36B
Q3 202211/4/20221.34B
Q2 20228/2/20221.36B
Q1 20224/29/20221.34B
Q4 20212/17/20221.37B
Q3 202111/3/20211.35B
Q2 20218/9/20211.28B
Q1 20214/29/20211.21B
Q4 20202/18/20211.14B
Q3 202010/29/20201.10B
Q2 20208/6/20201.01B
Q1 20204/30/20201.16B
Q4 20192/20/20201.21B
Q3 201910/31/20191.18B
Q2 20198/6/20191.17B
Q1 20195/9/20191.12B
Q4 20183/18/20191.15B
Q3 201811/6/20181.11B
Q2 20188/2/20181.07B
Q1 20185/9/20181.06B
Q4 20172/28/2018750.47M
Q3 201711/9/2017592.21M
Q2 20177/27/2017258.09M
Q1 20175/10/2017252.08M
Q4 20162/28/2017262.98M
Q3 201610/31/2016259.56M
Q2 20167/28/2016258.80M
Q1 20165/2/2016249.00M
Q4 20152/25/2016241.36M
Q3 201510/29/2015234.49M
Q2 20157/30/2015227.38M
Q1 20154/27/2015308.92M
Q4 20142/24/2015327.65M
Quotes delayed 20 minutes

Email EnvelopeFree SYNH Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Syneos Health (SYNH) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

SYRS Past Earnings
TALS Past Earnings
TARA Past Earnings
TARS Past Earnings
TBIO Past Earnings
TCDA Past Earnings
TCMD Past Earnings
TCON Past Earnings
TCRR Past Earnings
TCRT Past Earnings

SYNH Past Earnings Q&A

What was the best and worst SYNH past earnings results?
For Syneos Health, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest SYNH past earnings result in our data set was 1.480/share posted in Q4 2021, while the lowest was in Q2 2023 when SYNH posted 0.010/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q4 2021 when SYNH reported 1.37B in revenue, while the quarter with the lowest revenue in our data set was Q2 2015 at 227.38M of revenue.

  Suggested answer: There are 35 SYNH past earnings results in our data set.

On this page we presented the SYNH past earnings date information for Syneos Health. Reviewing that SYNH Past Earnings for the company, we see that the highest past earnings result in our data set was in Q4 2021, when SYNH posted earnings of 1.480/share. Meanwhile the lowest SYNH past earnings result was in Q2 2023, when SYNH posted earnings of 0.010/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q4 2021 when SYNH reported 1.37B in revenue, while the smallest revenue quarter was Q2 2015 when SYNH reported 227.38M in revenue.

Any self directed investor doing their due diligence on SYNH or any other given stock can benefit from researching all of the Syneos Health past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you to make it easy for investors to investigate Syneos Health past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for SYNH. Thanks for visiting, and the next time you need to research SYNH past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: Funds Holding FSTX, JYF Historical Stock Prices, IYR Options Chain.


SYNH Past Earnings | | Copyright © 2020 - 2023, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Wait! Don't leave yet.
Want to receive our latest research absolutely free?

Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.1%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.1%.